New flu shot on the way as FDA approves Moderna’s mRNA-based vaccine

The shot, named mFlusiva, is intended for adults age 50 or older

New flu shot on the way as FDA approves Moderna’s mRNA-based vaccine
The shot, named mFlusiva, is intended for adults age 50 or older